Stephen P. Robertson's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 34,638 Common Stock done at an average price of $14.4 . Disclosure was reported to the exchange on Feb. 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.40 per share. | 20 Feb 2026 | 34,638 | 483,296 (0%) | 0% | 14.4 | 498,787 | Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 48,558 | 557,434 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.95 per share. | 02 Jan 2026 | 40,385 | 517,934 (0%) | 0% | 16.0 | 644,141 | Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 128,438 | 128,438 | - | - | Employee Stock Option (right to buy) | |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 102,406 | 631,755 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 84,106 | 529,349 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 28 Feb 2025 | 64,872 | 566,883 (0%) | 0% | 8 | 518,976 | Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 7.92 per share. | 28 Feb 2025 | 57,607 | 509,276 (0%) | 0% | 7.9 | 456,247 | Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 06 Mar 2024 | 57,745 | 443,824 (0%) | 0% | 5.6 | 323,372 | Common Stock |
| Aurinia Pharma Inc | P. Robertson Stephen | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 194,230 | 501,569 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 204,810 | 322,766 (0%) | 0% | - | Common Stock | |
| Aurinia Pharma Inc | Stephen Robertson P. | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 8.78 per share. | 02 Mar 2023 | 19,644 | 303,122 (0%) | 0% | 8.8 | 172,474 | Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 02 Mar 2023 | 19,402 | 303,364 (0%) | 0% | 8.9 | 173,454 | Common Stock |